hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

Matrix Laboratories (part of Mylan Laboratories)

Headquarters in Netherlands

http://www.mylan.com/

🔎 Run a search for “Matrix Laboratories (part of Mylan Laboratories)”

Get RSS feed of these results

All stories

Article
7 August 2009

Clinton Foundation Reaches Deal With Matrix, Pfizer To Cut Prices For Second-Line ARVs, TB Drug

Author: Kaiser Daily Global Health Policy Report [USA]

Former President Bill Clinton on Thursday announced deals with drugmakers Matrix Laboratories [part of Mylan] and Pfizer to lower the cost of medications to treat patients with drug-resistant HIV in the developing world…the 2010 cost for the four...

Read more

Story
9 October 2008

Major drug firms agree with Ban Ki-Moon to invest more in AIDS treatments & diagnostics for poor regions

See full story

Article
9 October 2008

Secretary-General's statement following meeting with pharmaceutical and diagnostic companies working on HIV and AIDS

Author: United Nations

I met today with senior executives of seventeen of the world's research-based and generic pharmaceutical and diagnostic companies…to review progress on...expand[ing] access to HIV prevention, treatment, care and support services in low- and middle...

Read more

Article
29 April 2008

Deal lowers price of second-line therapy and makes new paediatric formulations available to poorer countries

Author: Michael Carter, Aidsmap

Further reductions in the prices of generic versions of key second-line antiretroviral drugs were announced yesterday, thanks to an agreement negotiated by the international drug purchase fund UNITAID and the Clinton HIV/AIDS Initiative with Indian...

Read more

Article
23 June 2007

Thailand to buy more generic drugs from India

Author: Bloomberg

Thailand plans to buy more generic AIDS drugs from India to cut the cost of treating its poorest patients after failing to win large enough discounts from drug makers including Merck & Co. and Abbott Laboratories…Public health minister, Mongkol Na...

Read more

Article
9 May 2007

Clinton Foundation Announces a Bargain on Generic AIDS Drugs

Author: Celia W. Dugger, New York Times

...Bill Clinton announced yesterday that his foundation had negotiated deep price reductions for generic versions of costly, second-line AIDS drugs...as well as for less toxic, easier-to-use first-line medicines...Mr. Clinton also forcefully endorsed...

Read more

Article
11 August 2006

Student AIDS Activists Applaud Breakthrough in Gilead’s Policies on AIDS Drugs for Global

Author: Matthew Kavanagh, Student Global AIDS Campaign

The Student Global AIDS Campaign (SGAC) is applauding what it calls “important steps forward and major new promises” taken by Gilead in making its AIDS drugs Tenofovir (Viread) and Truvada affordable and available in Africa and the global South. The...

Read more

Article
8 August 2006

Gilead Gives Up Trade Secrets to Get AIDS Drugs to Poor Nations

Author: Marni Leff Kottle , Bloomberg News [US}

Gilead Sciences Inc., maker of the world's best-selling AIDS treatment, is offering to help generic-drug makers in India produce the medicine, a move intended to get the life-saving pill to millions more people in the world's poorest countries. Since...

Read more

Story
8 August 2006

Gilead offers trade secrets to generic firms to help them make its AIDS drug more cheaply

See full story

Article
12 January 2006

New Agreements to Lower Prices of HIV/AIDS Rapid Tests and Second-line Drugs - Agreements with Nine Companies Will Lower Prices of HIV Diagnosis and Two HIV/AIDS Medicines by 30-50 Percent for 50 Countries

Author: Clinton Foundation

President Bill Clinton announced today that his foundation’s HIV/AIDS Initiative has negotiated new pricing agreements to lower the prices of HIV diagnosis and two antiretrovirals (ARVs). Four companies—Chembio (U.S.), Orgenics (Israel; a subsidiary...

Read more